Pancreatic Cancer Research

ResearcherTUM KlinikumActive in the last 2 years

Alexander Herner

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3905-9280; OpenAlex author ID A5014041995. Sources: OpenAlex.

Their work

Papers
8 (first author 4, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
54
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: none · 2014: none · 2015: 2 papers · 2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: 2 papers · 2025: none · 2026: 1 paper

Papers 8

  1. Author Correction: Combined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarc… First author DOI 10.1038/s41591-026-04234-8↗
  2. Author Correction: Combined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarc… First author DOI 10.1038/s41591-024-03054-y↗
  3. Comparison of endoscopic ultrasound-guided fine-needle aspiration and fine-needle biopsy to generate pancreatic cancer organoids: Randomized trial. Co-author DOI 10.1055/a-2257-3171↗
  4. Implementing cell-free DNA of pancreatic cancer patient-derived organoids for personalized oncology. Co-author DOI 10.1172/jci.insight.137809↗
  5. Modeling Therapy Response and Spatial Tissue Distribution of Erlotinib in Pancreatic Cancer. Co-author DOI 10.1158/1535-7163.mct-15-0165↗
  6. Current methods in mouse models of pancreatic cancer. First author DOI 10.1007/978-1-4939-2297-0_9↗
  7. Combined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarcinoma. First author DOI 10.1038/nm.3952↗
  8. Glutamate increases pancreatic cancer cell invasion and migration via AMPA receptor activation and Kras-MAPK signaling. Co-author DOI 10.1002/ijc.25898↗

Closest collaborators

The 25 strongest of 54 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Roland Michael Schmid · 6 shared papers, 2015–2026 · strength 0.68
  2. Jens Thomas Siveke · 6 shared papers, 2015–2026 · strength 0.56
  3. Rickmer Braren · 5 shared papers, 2015–2026 · strength 0.49
  4. Iréne Esposito · 5 shared papers, 2011–2026 · strength 0.45
  5. Pawel Karol Mazur · 4 shared papers, 2015–2026 · strength 0.45
  6. Irina Heid · 4 shared papers, 2015–2026 · strength 0.44
  7. Matthias Wirth · 4 shared papers, 2015–2026 · strength 0.44
  8. Mert Erkan · 4 shared papers, 2011–2026 · strength 0.40
  9. Jorg H. Kleeff · 4 shared papers, 2011–2026 · strength 0.40
  10. Marija Trajkovic‐Arsic · 3 shared papers, 2015–2026 · strength 0.37
  11. Stephano S. Mello · 3 shared papers, 2015–2026 · strength 0.37
  12. Bence Sipos · 3 shared papers, 2015–2026 · strength 0.37
  13. Julien Sage · 3 shared papers, 2015–2026 · strength 0.37
  14. Stephan A. Hahn · 3 shared papers, 2015–2026 · strength 0.37
  15. Elisabeth Heßmann · 3 shared papers, 2015–2026 · strength 0.37
  16. Laura D Attardi · 3 shared papers, 2015–2026 · strength 0.37
  17. Simone Hausmann · 3 shared papers, 2015–2026 · strength 0.37
  18. Volker Ellenrieder · 3 shared papers, 2015–2026 · strength 0.37
  19. Tyler Jacks · 3 shared papers, 2015–2026 · strength 0.37
  20. Felix Orben · 2 shared papers, 2020–2024 · strength 0.25
  21. Maximilian Reichert · 2 shared papers, 2020–2024 · strength 0.25
  22. Christoph Schlag · 2 shared papers, 2020–2024 · strength 0.25
  23. Günter Schneider · 2 shared papers, 2020–2024 · strength 0.25
  24. Guido von Figura · 2 shared papers, 2020–2024 · strength 0.25
  25. Johannes Roman Wiessner · 1 shared paper, 2024 · strength 0.18

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.